Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Powder for Sternal Wound Infection Prevention
NCT06651268Phase 2Not yet recruiting
- Sponsor
- Liaquat National Hospital & Medical College
- Start
- Nov 2024
- Primary completion
- Aug 2025
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vancomycin in sternal wound infection (2 arms), sponsored by Liaquat National Hospital & Medical College. Primary endpoint: Incidence of sternal wound infections at 1 month. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
vancomycin
03
Conditions
sternal wound infection
Beyond the preview
Go deeper on NCT06651268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06651268.